CVE-2026-13277Security vulnerabilities have been addressed in IBM Verify Identity Access and IBM Security Verify Access
Updated under an hour ago ()
Does this affect you?
It affects IBM Verify Identity Access and 3 other products. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
IBM Verify Identity Access could allow a remote attacker to conduct phishing attacks, using an open redirect attack. By persuading a victim to visit a specially crafted Web site, a remote attacker could exploit this vulnerability to spoof the URL displayed to redirect a user to a malicious Web site that would appear to be trusted. This could allow the attacker to obtain highly sensitive information or conduct further attacks against the victim.
- CVSS
- 4.7 MEDIUM (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:N/I:L/A:N
- Weakness (CWE)
- CWE-601
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- ibm
- NVD analysis
- Awaiting Analysis
- Record last updated
- Sep 15, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
IBM Verify Identity Access ibm:verify_identity_access | from 11.0.0 through 11.0.3 Interim Fix 001 | CNA record |
IBM Security Verify Access ibm:security_verify_access | from 10.0.0 through 10.0.9.2 Interim Fix 001 | CNA record |
IBM Verify Identity Access Container ibm:verify_identity_access_container | from 11.0.0 through 11.0.3 Interim Fix 001 | CNA record |
IBM Security Verify Access Container ibm:security_verify_access_container | from 10.0.0 through 10.0.9.2 Interim Fix 001 | CNA record |
References
- https://www.ibm.com/support/pages/node/7286188vendor-advisory, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.